Substance abuse as a risk factor for tardive dyskinesia: A retrospective analysis of 1,027 patients 1

Psychopharmacology Bulletin

Volumn 33, Issue 1, 1997, Pages 177-181

  Bailey, LaGenia ^a   Maxwell, Sarz ^b,c   Brandabur, Melanie M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Center for Addictive Problems   (United States)

^c NONE   (United States)

Author keywords

Antipsychotic side effects; Dual diagnosis, NMDA receptor; Substance abuse; Tardive dyskinesia

Indexed keywords

ALCOHOL; CLOZAPINE; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; ALCOHOL ABUSE; ARTICLE; CANNABIS ADDICTION; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOIDISM; SCHIZOPHRENIA; SUBSTANCE ABUSE; TARDIVE DYSKINESIA;

EID: 0030935548     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: The Association, 1987.
2. Baldessarini, RJ. Clinical and epidemiologic aspects of tardive dyskinesia. J. Clin. Psychiatry 46:8-13, 1985.
3. Baldessarini, RJ; Cole, JO; Davis, JM; Simpson, G; Tarsy, D; Gardos, G; and Preskorn, SH. Tardive Dyskinesia: Summary of a Task Force Report of the American Psychiatric Association. Am. J. Psychiatry 137:1163-1172, 1980.
4. Beel, MF; Ferrante, RJ; Swartz, KJ; and Kowall, NW. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1649-1659, 1991.
5. Cardoso, F, and Jankovic, J. Movement disorders. Neurologic complications of drug and alcohol abuse. Neurol. Clin. 11:625-638, 1993.
6. Charness, ME. Brain lesions in alcoholics. Alcohol.: Clin. Exp. Res. 17:2-11, 1993.
7. Chiu, HFK; Wing, YK; Kwong, PK; Leung, CM; and Lam, LCW. Prevalence of tardive dyskinesia in samples of elderly people in Hong Kong. Acta Psychiatr. Scand. 87:266-268, 1993.
8. Cohen, S; Khan, A; Zheng, Y; and Chiles, J. Tardive dyskinesia in the mentally retarded: Comparison of prevalence, risk factors and topography with a schizophrenic population. Acta Psychiatr. Scand. 83:234-237, 1991.
9. Daras, M; Koppel, BS; and Atos-Radzion, E. Cocaine-induced choreoathetoid movements ("crack dancing"). Neurology 44:751-752, 1994.
10. Dawson, TM; Dawson, VL; and Snyder, SH. A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann. Neurol. 32:297-311, 1992.
11. Dixon, L; Weiden, PJ; Haas, G; Sweeney, J; and Frances, AJ. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr. Psychiatry 33:121-122, 1992.
12. Drake, RE; Bartels, SJ; Teague, GB; Noordsy, DI; and Clark, RE. Treatment of substance abuse in severely mentally ill patients. J. Nerv. Ment. Dis. 181:606-611, 1993.
13. Elliott, KJ; Lewis, S; El-Mallakh, RS; Looney, SW; Caudill, R; and Bacani-Oropilia, T. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia. Ann. Clin. Psychiatry 6:197-203, 1994.
14. Fornazzari, I, and Carlen, PL. Transient choreiform dyskinesias during alcohol withdrawal. Can. J. Neurol. Sci. 9:89-90, 1982.
15. Haas, G; Sweeney, J; and Frances, A. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr. Psychiatry 33:121-122, 1992.
16. Jeste, DV; Caligiuri, MP; Paulsen, JS; Heaton, RK; Lacro, JP; Harris, MJ; Bailey, A; Fell, RL; and McAdams, LA. Risk of tardive dyskinesia in older patients. Arch. Gen. Psychiatry 52:756-765, 1995.
17. Kieburtz, K; Feigin, A; McDermott, M; Como, P; Abwender, D; Zimmerman, C; Hickey, C; Orme, C; Claude, K; Sotack, J; Greenamyre, JT; Dunn, C; and Shoulson, I. A controlled trial of remacemide hydrochloride in Huntington's disease. Mov. Disord. 11:273-277, 1996.
18. Lancaster, FE. Alcohol, nitric oxide, and neurotoxicity: Is there a connection?-A review. Alcohol Clin. Exp. Res. 16:539-541, 1992.
19. Miller, R, and Chouinard, G. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biol. Psychiatry 34:713-738, 1993.
20. Mueser, KT; Yarnold, PR; Levinson, DF; Singh, H; Bellack, AS; Kee, K; Morrison, RL; and Yadalam, KG. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr. Bull. 16(1):31-55, 1990.
21. Mullin, PJ; Kershaw, PW; and Bolt, JM. Choreoathetotic movement disorder in alcoholism. Br. Med. J. 4:279-281, 1970.
22. Olivera, A; Kiefer, M; and Manley, N. Tardive dyskinesia in psychiatric patients with substance use disorders. Am. J. Drug Alcohol Abuse 16:57-66, 1990.
23. O'Malley, S; Jaffe, AJ; Rode, S; and Rounsaville, BJ. Experience of a "slip" among alcoholics treated with naltrexone or placebo. Am. J. Psychiatry 53:281-283, 1996.
24. Sax, DS; Kometsky, C; and Kim, A. Lack of hepatotoxicity with naltrexone treatment. J. Clin. Pharmacol. 34:898-901, 1994.
25. Schooler, NR, and Kane, JM. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 39:486-487, 1982.
26. Smiley, PL; Johnson, M; Bush, L; Gibb, JW; and Hanson, GR. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 255:938-942, 1990.
27. Soni, SD, and Browlee, M. Alcohol abuse in chronic schizophrenics: Implications for management in the community. Acta Psychiatr. Scand. 84:272-276, 1991.
28. Sprague, RL, and Kalachnik, JE. Reliability, validity and a total score cut-off for the Dyskinesia Identification System (DISCUS) with mentally ill and mentally retarded populations. Psychopharmacol. Bull. 27(1):51-58, 1991.
29. Tanner, C. Drug-induced movement disorders (tardive dyskinesia and dopa-induced dyskinesia). In: Vinken, PJ; Bruyn, GW; and Klawans, HL, eds. Handbook of Clinical Neurology, Vol. 5(49): Extrapyramidal Disorders. New York: Elsevier Science Publishers, 1986.
30. Walker, RD; Howard, MO; Lambert, MD; and Suchinsky, R. Psychiatric and medical comorbidities of veterans with substance use disorders. Hosp. Comm. Psychiatry 45:232-237, 1994.
31. Weiner, WJ, and Lang, AE. Movement Disorders: A Comprehensive Survey. Mount Kisco, NY: Futura Publishing Company, 1989.